HomePharma

Pharma

Pharma

Astria Therapeutics Begins Enrolling European Patients in Phase 3 ALPHA-ORBIT Trial for Hereditary Angioedema

Life Sciences Times - 0
Pharma

Enveric Biosciences Achieves Key Manufacturing Milestones for Lead Drug Candidate EB-003

Life Sciences Times - 0
Pharma

Alnylam Doses First Patient in ZENITH Global Phase 3 Trial of Zilebesiran for Cardiovascular Outcomes

Life Sciences Times - 0
Pharma

Ensem Therapeutics’ ETX-636 Receives FDA Fast Track Designation for Advanced Breast Cancer

Life Sciences Times - 0
Pharma

Faeth Therapeutics Expands Metabolism-Based R&D Platform Into Rare Pediatric Disease

Life Sciences Times - 0
Pharma

Study Finds Nalmefene Auto-Injector Works Faster and Longer Than Intranasal Naloxone in Fentanyl-Induced Respiratory Depression

Life Sciences Times - 0
Pharma

New HELIOS-B Data Show Vutrisiran Reduces Gastrointestinal Events in ATTR-CM Patients

Life Sciences Times - 0
Pharma

ENHERTU Shows Superior Results in Phase III Breast Cancer Trial

Life Sciences Times - 0
Pharma

Bayer Canada Partners with Mint Pharmaceuticals to Distribute ADALAT XL in Canada

Life Sciences Times - 0
Pharma

FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Life Sciences Times - 0
Pharma

Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy

Life Sciences Times - 0
Pharma

FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations

Life Sciences Times - 0
1...101112...91Page 11 of 91

Most Read